SCHEMBL1386845

SCHEMBL1386845

CCN(CC)CCn1cc(-c2ccccc2)c(OCc2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.41
BCHE P06276 4/20 0.39
SIGMAR1 Q99720 1/20 0.39
SQOR Q9Y6N5 1/20 0.38
KCNH2 Q12809 2/20 0.37
MCHR1 Q99705 1/20 0.37
MAOB P27338 1/20 0.37
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
CYP1A2 P05177 1/20 0.36
LTA4H P09960 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2577840 0.99 PDE10A (0.41) PDE10ABCHESIGMAR1SQORKCNH2
Oxalic Acid SCHEMBL2575385 0.94 L3MBTL1 (0.46) PDE10AKCNH2MCHR1MAOBSCN1A
SCHEMBL1385049 0.88 PDE10A (0.43) PDE10ASQORKCNH2GABRA1GABRG2
Hydrochloric Acid SCHEMBL2577843 0.86 PDE10A (0.42) PDE10ASQORKCNH2GABRA1GABRG2
SCHEMBL1384073 0.84 CNR2 (0.47) PDE10ABCHESQORKCNH2MCHR1
SCHEMBL1384547 0.84 PDE10A (0.42) PDE10ASQORKCNH2MCHR1GABRA1
Hydrochloric Acid SCHEMBL2579429 0.83 CNR2 (0.46) PDE10ABCHESQORKCNH2MCHR1
Hydrochloric Acid SCHEMBL2575915 0.83 POLB (0.42) PDE10ASQORKCNH2MCHR1GABRA1
SCHEMBL1387091 0.82 MAOB (0.46) PDE10ASQORMAOBGABRA1GABRG2
Hydrochloric Acid SCHEMBL2581597 0.81 MAOB (0.45) PDE10ASQORMAOBGABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4833078-B2 2011-12-07 JP claimed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP claimed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO claimed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO claimed
EP-1689720-B1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2009-04-15 EP disclosed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP disclosed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO disclosed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO disclosed